The theme of the 12th annual Business of Regenerative Medicine conference at Harvard Business School is Defining and Creating Value.
Over two days of panel discussions, presentations, and networking, our distinguished speakers will provide insights – as well as guardrails – for navigating the emerging industry of regenerative medicine.
Chief Executive Officer Keith Thompson will be taking part in the following panel discussion:
Turning early scientific value into commercial value
10:30-11:30, Monday 15 July